TrialDiabetologia2010

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials.

P D Home et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.